Back to Authors

Gould, Michael K.

https://orcid.org/0000-0001-6749-8315

Mayo Clinic

Kaiser Permanente Bernard J. Tyson School of Medicine

Citations 4

Training the next generation of learning health system scientists
Lozano, Paula , Lane‐Fall, Meghan B. , Franklin, Patricia D. , Rothman, Russell L. , Gonzales, Ralph , Ong, Michael , Gould, Michael K. , Beebe, Timothy J. , Roumie, Christianne L. , Mendonça, Eneida A. , Starrels, Joanna L. , Sarkar, Urmimala , Savitz, Lucy A., Moon, JeanHee, Ralston, James D. , Chesley, Francis D. , Lozano, Paula M , Enders, Felicity T, Guise, Jeanne‐Marie , Enders, Felicity , Forrest, Christopher B. , Linzer, Mark

Learning Health Systems | September 10, 2022 | Volume: 6 | Issue: 4 | Pages: No page available

10.1002/lrh2.10342 Get It

AbstractIntroductionThe learning health system (LHS) aligns science, informatics, incentives, stakeholders, and culture for continuous improvement and innovation. The Agency for Healthcare Research and Quality and the Patient‐Centered Outcomes Research Institute designed a K12 initiative to grow the number of LHS scientists. We describe approaches developed by 11 funded centers of excellence (COEs) to promote partnerships between scholars and health system leaders and to provide mentored research training.MethodsSince 2018, the COEs have enlisted faculty, secured institutional resources, partnered with health systems, developed and implemented curricula, recruited scholars, and provided mentored training. Program directors for each COE provided descriptive data on program context, scholar characteristics, stakeholder engagement, scholar experiences with health system partnerships, roles following program completion, and key training challenges.ResultsTo date, the 11 COEs have partnered with health systems to train 110 scholars. Nine (82%) programs partner with a Veterans Affairs health system and 9 (82%) partner with safety net providers. Clinically trained scholars (n = 87; 79%) include 70 physicians and 17 scholars in other clinical disciplines. Non‐clinicians (n = 29; 26%) represent diverse fields, dominated by population health sciences. Stakeholder engagement helps scholars understand health system and patient/family needs and priorities, enabling opportunities to conduct embedded research, improve outcomes, and grow skills in translating research methods and findings into practice. Challenges include supporting scholars through roadblocks that threaten to derail projects during their limited program time, ranging from delays in access to data to COVID‐19‐related impediments and shifts in organizational priorities.ConclusionsFour years into this novel training program, there is evidence of scholars' accomplishments, both in traditional academic terms and in terms of moving along career trajectories that hold the potential to lead and accelerate transformational health system change. Future LHS training efforts should focus on sustainability, including organizational support for scholar activities.
Methods for the Watch the Spot Trial. A Pragmatic Trial of More- versus Less-Intensive Strategies for Active Surveillance of Small Pulmonary Nodules
Gould, Michael K. , Kelly, Karen , Altman, Danielle, Bie, Evan de, Dyer, Debra S. , Barbosa, Eduardo J. Mortani , Qi, Lihong , Vaszar, Laszlo T. , Yu, Sophronia , Miglioretti, Diana L. , Miglioretti, Diana L , Kelly, Karen , Smith‐Bindman, Rebecca , Barjaktarević, Igor , Creekmur, Beth , Mularski, Richard A.

Annals of the American Thoracic Society | July 17, 2019 | Volume: 16 | Issue: 12 | Pages: 1567-1576

10.1513/annalsats.201903-268sd Get It

Abstract Small pulmonary nodules are most often managed by surveillance imaging with computed tomography (CT) of the chest, but the optimal frequency and duration of surveillance are unknown. The Watch the Spot Trial is a multicenter, pragmatic, comparative-effectiveness trial with cluster randomization by hospital or health system that compares more- versus less-intensive strategies for active surveillance of small pulmonary nodules. The study plans to enroll approximately 35,200 patients with a small pulmonary nodule that is newly detected on chest CT imaging, either incidentally or by screening. Study protocols for more- and less-intensive surveillance were adapted from published guidelines. The primary outcome is the percentage of cancerous nodules that progress beyond American Joint Committee on Cancer seventh edition stage T1a. Secondary outcomes include patient-reported anxiety and emotional distress, nodule-related health care use, radiation exposure, and adherence with the assigned surveillance protocol. Distinctive aspects of the trial include: 1) the pragmatic integration of study procedures into existing clinical workflow; 2) the use of cluster randomization by hospital or health system; 3) the implementation and evaluation of a system-level intervention for protocol-based care; 4) the use of highly efficient, technology-enabled methods to identify and (passively) enroll participants; 5) reliance on data collected as part of routine clinical care, including data from electronic health records and state cancer registries; 6) linkage with state cancer registries for complete ascertainment of the primary study outcome; and 7) intensive engagement with a diverse group of patient and nonpatient stakeholders in the design and execution of the study.
Favorable Stage Distribution in the NELSON Trial
Midthun, David E. , Gould, Michael K.

American Journal of Respiratory and Critical Care Medicine | April 15, 2013 | Volume: 187 | Issue: 8 | Pages: 792-793

10.1164/rccm.201302-0314ed Get It